Search for: "Astrazeneca" Results 1121 - 1140 of 1,246
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
11 Jul 2008, 4:30 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
8 Jul 2008, 4:25 am
By Sherri Oslick -- Late last week, Judge Pisano of the District Court of New Jersey granted summary judgment of no inequitable conduct in favor of AstraZeneca in its consolidated Paragraph IV litigation against Teva Pharmaceuticals and Sandoz, Inc. over AstraZeneca's antipsychotic drug Seroquel ®. [read post]
7 Jul 2008, 7:06 pm
One clue may be found in list of donors who include McDonald-whose fast-food has contributed mightily to US children's obesity and cholesterolepidemic-and pharmaceutical companies that market statins, such as, AstraZeneca (Crestor), Sanofi-Aventis (Zocor), Merck (Mevacor, Vytorin). [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade Representative over Special 301… [read post]
4 Jul 2008, 3:27 pm
AstraZeneca sued Teva in September 2005 for willful infringement of Orange book listed US 4,879,288 protecting Seroquel drug substance Quetiapine Fumarate. [read post]
2 Jul 2008, 8:54 pm
In the trial with AstraZeneca Pharmaceuticals in February, a jury awarded $115 million (later reduced to $160 million). [read post]
2 Jul 2008, 5:36 am
District Judge Joel Pisano in Trenton, New Jersey ruled in favor of AstraZeneca in the Seroquel matter on July 1, and AstraZeneca can ask Judge Pisano to block Teva and Sandoz from getting U.S. regulatory approval to sell copies of Seroquel until the patent expires in 2011.Bloomberg noted: AstraZeneca is trying to broaden Seroquel's use to keep revenue rising as sales of its No. 1 product, the Nexium ulcer treatment, fall. (...) [read post]
20 Jun 2008, 8:07 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
19 Jun 2008, 8:55 pm
A few months ago, an Alabama jury awarded $40 million in compensatory damages and $175 million in punitive damages against AstraZeneca (the maker of Nexium and Crestor). [read post]
13 Jun 2008, 8:29 am
DISTRICT COURTSOUTHERN DISTRICT OF NEW YORKBusiness LawAstraZeneca Share Manipulation Claims Dismissed On Jurisdiction Grounds, Failure to Plead ScienterIn re AstraZeneca Securities LitigationU.S. [read post]
13 Jun 2008, 3:40 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
12 Jun 2008, 9:35 pm
To say the least, AstraZeneca expressed disappointment with the ruling of noninfringement regarding it’s U.S. [read post]
12 Jun 2008, 3:22 am
Cir. 2008) Yesterday, the Court of Appeals for the Federal Circuit affirmed a June 2007 district court decision finding that Mylan's generic version of Prilosec (omeprazole) does not infringe two AstraZeneca patents, U.S. [read post]
11 Jun 2008, 9:47 pm
And lest you think this idea of foreign companies and personnel being pursued for FCPA violations is a purely hypothetical one, I suggest you also check out this post, entitled, "Europe Discovers the FCPA," which lists the following European companies "currently under FCPA investigation by US authorities:" ABB (Switzerland, energy) Alcatel Lucent (France, communications) AstraZeneca (UK-Sweden, pharmaceuticals) BAE Systems (UK, defense) Daimler (Germany, automotive)… [read post]
10 Jun 2008, 4:20 pm
Mylan and others challenged Astrazeneca’s patents on grounds that their generic formulations do not infringe two Astra’s listed patents. [read post]
10 Jun 2008, 3:15 am
 The complaint essentially alleges that Exanta, a pharmaceutical being develop by the AstraZeneca (a U.K. [read post]
6 Jun 2008, 6:49 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
30 May 2008, 9:09 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]